Eurocine Vaccines receives the Nordic Stars Award 2016

Eurocine Vaccines received the Nordic Stars Award 2016 at the Nordic Life Science Days in Stockholm.
–  We were thrilled to bring our recently approved Clinical Trial Application to the partnering meetings at the Nordic Life Science Days NLSD, says Hans Arwidsson, CEO of Eurocine Vaccines. Receiving the Nordic Stars Award as an acknowledgement of our committed efforts, adds even more power and spirit to the everyday endeavors in the team, Dr. Arwidsson continues.newjustification_nlsd

Nordic Stars Award is a prize highlighting early and exciting Nordic life science companies. It was established in 2013 with the
purpose of rewarding particularly innovative companies belonging to the Nordic life science community contributing for the benefit of patients, industry and society alike.

Nordic Life Science Days has become an established arena for high quality meetings between investors, global life science companies and Nordic innovations. It has grown rapidly to become the largest annual Life Science Invest and Partnering meeting in the Nordic region with nearly 700 companies represented in the activities with the number of delegates approaching 1100.

– The price is not only a recognition of our dedicated efforts in the vaccine field, says Michael Wolff Jensen, Chairman of the Board of Eurocine Vaccines. The award also acknowledges the importance of addressing unmet medical needs and thereby improving quality of life for patients and their families, Mr. Wolff Jensen concludes.

For more information, please contact CEO Hans Arwidsson

Additional information:
Press Release from NLSD – Winners of Nordic Stars Award 2016

Article in Life Science Sweden – De är årets nordiska stjärnor (Swedish)

Nordic Life Science Days, NLSD

Download this news as document here 

Do you want to follow Eurocine Vaccines development?

Share our ambition developing more effective vaccines. Fill in your e-mail address and we will update you with the latest Press Releases and Stories.

Start your subscription here »